These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28551519)
1. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery. Chantaburanan T; Teeranachaideekul V; Chantasart D; Jintapattanakit A; Junyaprasert VB J Colloid Interface Sci; 2017 Oct; 504():247-256. PubMed ID: 28551519 [TBL] [Abstract][Full Text] [Related]
2. Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions. Chantaburanan T; Teeranachaideekul V; Jintapattanakit A; Chantasart D; Junyaprasert VB Int J Pharm X; 2023 Dec; 6():100205. PubMed ID: 37609107 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Jensen LB; Magnussson E; Gunnarsson L; Vermehren C; Nielsen HM; Petersson K Int J Pharm; 2010 May; 390(1):53-60. PubMed ID: 19836439 [TBL] [Abstract][Full Text] [Related]
5. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
6. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN). Heider M; Hause G; Mäder K Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354 [TBL] [Abstract][Full Text] [Related]
7. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery. Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471 [TBL] [Abstract][Full Text] [Related]
8. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo. Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809 [TBL] [Abstract][Full Text] [Related]
10. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136 [TBL] [Abstract][Full Text] [Related]
11. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line. Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410 [TBL] [Abstract][Full Text] [Related]
12. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes. Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of solid lipid nanoparticles containing peptide. Hu FQ; Hong Y; Yuan H Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127 [TBL] [Abstract][Full Text] [Related]
14. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Abdel-Mottaleb MM; Neumann D; Lamprecht A Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818 [TBL] [Abstract][Full Text] [Related]
16. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants. Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048 [TBL] [Abstract][Full Text] [Related]
17. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine. Wen LX; Ding HM; Wang JX; Chen JF J Nanosci Nanotechnol; 2006; 6(9-10):3139-44. PubMed ID: 17048529 [TBL] [Abstract][Full Text] [Related]
18. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats. Rahman MA; Harwansh RK; Iqbal Z Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786 [TBL] [Abstract][Full Text] [Related]